The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.50
Bid: 68.00
Ask: 69.00
Change: 2.50 (3.76%)
Spread: 1.00 (1.471%)
Open: 68.00
High: 69.00
Low: 65.50
Prev. Close: 66.50
TRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM and Result of Placing and Open Offer

10 Jul 2023 12:03

RNS Number : 5194F
TruFin PLC
10 July 2023
 

10 July 2023

TruFin plc

("TruFin" or the "Company")

Result of General Meeting and

Result of Placing and Open Offer

TruFin plc completes fundraising

On 22 June 2023, the Company announced a proposed Placing to raise £7.0 million and Open Offer to raise up to a further approximately £1.0 million (both amounts before expenses) through the issue of, in aggregate, up to 12,313,212 New Ordinary Shares at an issue price of 65 pence per New Ordinary Share.

The Company is pleased to announce that at its General Meeting held earlier today, all of the Resolutions set out in the circular published on 23 June 2023 were duly passed. 

Further to this, the Company can now confirm that it will issue, pursuant to the Placing and Open Offer, in aggregate, 11,653,744 New Ordinary Shares at 65 pence per New Ordinary Share, raising approximately £7.6 million. The issue of New Ordinary Shares will be split as follows:

· 10,769,230 New Ordinary Shares under the Placing, raising gross proceeds of £7.0 million; and

· 884,514 New Ordinary Shares taken up under the Open Offer, raising gross proceeds of approximately £0.6 million. Valid acceptances were received from Qualifying Shareholders in respect of 649,820 Open Offer Shares under their Basic Entitlements, and for 234,694 Open Offer Shares under the Excess Application Facility. Qualifying Shareholders who have validly applied for Open Offer Shares will receive their full Basic Entitlement. Applications for Open Offer Shares under the Excess Application Facility will be received in full.

Application has been made for 11,653,744 New Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will become effective and trading will commence in the New Ordinary Shares at 8.00 a.m. on 11 July 2023.

Following Admission, the total number of voting rights in the Company will be 105,836,687. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Defined terms used in this announcement have the meanings (unless the context otherwise requires) set out in the circular dated 23 June 2023, which is available on the Company's website (www.TruFin.com).

- ends -

Enquiries:

TruFin plc James van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward ThomasCara Murphy

 

0203 100 2000

 

About TruFin

TruFin plc is the holding company for an operating group of companies that are niche lenders and early payment providers. TruFin Group combines the benefits of both the traditional relationship banking model and developments in the fintech sector. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website www.TruFin.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFXEFEADEFA
Date   Source Headline
12th Apr 20247:01 amRNSBlock Admission Application
12th Apr 20247:00 amRNSGrant of share awards under LTIP
2nd Apr 20247:00 amRNSAppointment of Director to the Board of Playstack
26th Mar 20247:01 amRNSSale of Interact platform
25th Mar 20247:00 amRNSSatago signs contract with Bank of Ireland Finance
19th Mar 20247:00 amRNSNotice of Results and Investor Presentation
18th Mar 20247:00 amRNSPlaystack announces over 1m units sold for Balatro
12th Mar 202411:07 amRNSHolding(s) in Company
22nd Feb 20247:00 amRNSPlaystack releases its fastest selling game
8th Feb 20247:00 amRNSTrading Update
4th Jan 20247:00 amRNSTrading Update
20th Dec 20239:40 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSAppointment of INED to the Board of Oxygen
21st Nov 20237:00 amRNSPlaystack enters into LoI for sale of Interact
9th Nov 20237:00 amRNSOxygen Finance acquisition of bidstats.uk
18th Oct 20234:19 pmRNSHolding(s) in Company
5th Oct 20237:00 amRNSSale of Majority Holding in Vertus
29th Sep 20237:00 amRNSHalf-year Report
28th Sep 202312:07 pmRNSResult of AGM
14th Sep 20238:00 amRNSPlaystack releases award-winning game - AK-xolotl
29th Aug 20236:19 pmRNSNotice of AGM
21st Aug 20237:00 amRNSNon-Binding Offer for Vertus
28th Jul 20237:00 amRNSGrant of Share Awards under LTIP
18th Jul 20238:59 amRNSHolding(s) in Company
18th Jul 20238:58 amRNSHolding(s) in Company
18th Jul 20238:55 amRNSHolding(s) in Company
10th Jul 202312:03 pmRNSResult of GM and Result of Placing and Open Offer
23rd Jun 20237:00 amRNSResult of Placing and Notice of General Meeting
22nd Jun 20234:45 pmRNSProposed Placing and Open Offer
18th May 20233:04 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSOxygen Finance secures six Early Payment contracts
15th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
28th Feb 20235:43 pmRNSHolding(s) in Company
23rd Jan 20237:00 amRNSStatement re Satago
20th Jan 20237:00 amRNSStatement regarding Satago and Trading Update
22nd Dec 20227:00 amRNSRejected Indicative Offer for Oxygen
15th Nov 20227:00 amRNSOxygen surpasses £1b in early payment provision
3rd Nov 20227:00 amRNSPlaystack releases new console game
20th Oct 20227:00 amRNSSatago signs agreement with Sage
10th Oct 20227:00 amRNSNotice of Capital Markets Day
30th Sep 20227:00 amRNSPDMR Notification
20th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Capital Markets Day
25th Aug 20229:37 amRNSHolding(s) in Company
29th Jul 20229:00 amRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSSatago signs commercial agreement with Lloyds
1st Jul 20227:00 amRNSHolding(s) in Company
9th Jun 20227:00 amRNSSatago partnership with Sage and Lloyds
7th Jun 202211:19 amRNSResult of AGM
6th Jun 20227:00 amRNSStatement re Playstack

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.